Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin cream for facial melasma compared with hydroquinone
RBR-102t5vqcPhase 3Terminated
- Sponsor
- Federal University of São Paulo
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in melasma comparing Metformin cream, Metformin + nicotinamide cream and Hydroquinone cream control (3 arms). Started Mar 2025; status: terminated.
02
Drugs
metforminnicotinamidehydroquinone
03
Conditions
melasma
Beyond the preview
Go deeper on RBR-102t5vqc.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-102t5vqc.